Omics data integration facilitates target selection for new antiparasitic drugs against TriTryp infections

MARTIN RIVARA; MIRANDA CLARA PALUMBO; EZEQUIEL J SOSA; SANTIAGO RADIO; ADRIÁN G TURJANSKI; JOSÉ SOTELO; DARIO FERNANDEZ DO PORTO (#EQUAL CONTRIBUTOR); PABLO SMIRCICH (#EQUAL CONTRIBUTOR)

Frotniers in Pharmacology

Frontiers

Año: 2023

1663-9812

Trypanosoma cruzi, Trypanosoma brucei, and Leishmania spp., commonly referred to as TriTryps, are a group of protozoan parasites that cause important human diseases affecting millions of people belonging to the most vulnerable populations worldwide. Current treatments have limited efficiencies and can cause serious side effects, so there is an urgent need to develop new control strategies. Presently, the identification and prioritization of appropriate targets can be aided by integrative genomic and computational approaches. In this work, we conducted a genome-wide multidimensional data integration strategy to prioritize drug targets. We included genomic, transcriptomic, metabolic, and protein structural data sources, to delineate candidate proteins with relevant features for target selection in drug development. Our final ranked list includes proteins shared by TriTryps and covers a range of biological functions including essential proteins for parasite survival or growth, oxidative stress-related enzymes, virulence factors, and proteins that are exclusive to these parasites. Our strategy found previously described candidates, which validates our approach as well as new proteins that can be attractive targets to consider during the initial steps of drug discovery.